1-20 of 145 results for member:"Matt Hancock"
Librarians' tools
- Search time
- 0.219 seconds
- Solr query time
- 0.007 seconds
- Search query
- member:"Matt Hancock"
- We searched for
- member_ses:301034
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
Second reading. Agreed to on question. Programme motion relating to proceedings in Public Bill Committee, on consideration and up to and including third reading. Agreed to on question. Money resolution. Agreed to on question. Ways and means resolution. Agreed to on question.
Second reading. Agreed to on question. Programme motion relating to proceedings in Public Bill Committee, on consideration and up to and including third reading. Agreed to on question. Money resolution. Agreed to on question. Ways and means resolution. Agreed to on question.
I beg to move, That the Bill be now read a Second time.
While the world grapples with the challenge of coronavirus, it is vital that we do not lose sight of the important long-term reforms that we must make. Medicines and medical devices are evolving faster than ever. Not long...
I beg to move, That the Bill be now read a Second time.
While the world grapples with the challenge of coronavirus, it is vital that we do not lose sight of the important long-term reforms that we must make. Medicines and medical devices are evolving faster than ever. Not long...
We do not have a figure for medicines and medical devices specifically. As a nation, we have a goal that we should reach 2.4% of GDP spent on research. We are increasing the medical research budget; for instance, we are doubling the budget for research into dementia. As my right...
We do not have a figure for medicines and medical devices specifically. As a nation, we have a goal that we should reach 2.4% of GDP spent on research. We are increasing the medical research budget; for instance, we are doubling the budget for research into dementia. As my right...
It is almost as though the hon. Gentleman has read my speech. That is the broad intent of that part of the Bill. I will come to it in more detail in a moment, and I am glad about the constructive tone that has been adopted across the House when...
It is almost as though the hon. Gentleman has read my speech. That is the broad intent of that part of the Bill. I will come to it in more detail in a moment, and I am glad about the constructive tone that has been adopted across the House when...
Yes, that is right. This Bill empowers us to be able to move faster. Essentially, it empowers the UK to build a life sciences regulatory framework that is the best in the world—of course, working with EU partners, but also with partners from right around the world—and all with the...
Yes, that is right. This Bill empowers us to be able to move faster. Essentially, it empowers the UK to build a life sciences regulatory framework that is the best in the world—of course, working with EU partners, but also with partners from right around the world—and all with the...
In some cases it was possible to share that information but not in all cases, and it will be possible now. I have no doubt that the hon. Member, like others on the frontline, will have received some information, but the MHRA is currently limited in the information that it...
In some cases it was possible to share that information but not in all cases, and it will be possible now. I have no doubt that the hon. Member, like others on the frontline, will have received some information, but the MHRA is currently limited in the information that it...
I am sure that this debate will continue in Committee, but for clarity, those delegated powers existed under the European Communities Act 1972. The Bill proposes to replace existing delegated powers from the 1972 Act with new powers to make such regulations under the new Act. This is not a...
I am sure that this debate will continue in Committee, but for clarity, those delegated powers existed under the European Communities Act 1972. The Bill proposes to replace existing delegated powers from the 1972 Act with new powers to make such regulations under the new Act. This is not a...
To ask the Secretary of State for Health and Social Care, whether he plans to reassess the requirements established by the European Medicines Agency guidelines implementing EU Directive 2001/83/EC on Medicinal Products for Human Use which specify that two species of mammal, one a non-rodent, must be used in repeated...
To ask the Secretary of State for Health and Social Care, whether he plans to reassess the requirements established by the European Medicines Agency guidelines implementing EU Directive 2001/83/EC on Medicinal Products for Human Use which specify that two species of mammal, one a non-rodent, must be used in repeated...
The requirement to use two mammalian species (one a non-rodent) in repeated dose toxicity is part of the International Conference on Harmonisation guideline on ‘Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorisation for Pharmaceuticals’, ICH M3(R2). The overall objective of this internationally agreed guideline is the promotion of safe and ethical development of new pharmaceuticals while reducing the use of animals in accordance with the 3R principles (reduce/refine/replace).
There are no plans to reassess this requirement at present. The requirement is an integral part of a stepwise process involving an evaluation of both the animal and human safety information. The goals of the nonclinical safety evaluation generally include a characterisation of toxic effects with respect to target organs, dose dependence, relationship to exposure, and when appropriate, potential reversibility. Choice of species for nonclinical investigations are made based on scientific and ethical considerations. This information is important for how to test a candidate medicinal product in human trials, specifically for the estimation of an initial safe starting dose and dose range. The United Kingdom’s National Centre for the Replacement Refinement and Reduction of Animals in Research continues to research the utility of using dogs in such investigations.
I beg to move, That the clause be read a Second time.
I beg to move, That the clause be read a Second time.
The Data Protection Bill sets out a full new data protection regime for Britain, giving people more control over their data.
First, I wish to address new clauses 20 and 21, before turning to the other new clauses. These new clauses are essentially the provisions contained in sections 40 and 42...
The Data Protection Bill sets out a full new data protection regime for Britain, giving people more control over their data.
First, I wish to address new clauses 20 and 21, before turning to the other new clauses. These new clauses are essentially the provisions contained in sections 40 and 42...
I will come on to what has changed in the many years since 2013, not least of which is the fact that we now have a full-blown independent press regulator, the Independent Press Standards Organisation, which did not exist back then.
I will come on to what has changed in the many years since 2013, not least of which is the fact that we now have a full-blown independent press regulator, the Independent Press Standards Organisation, which did not exist back then.
We have three separate systems of media regulation in this country: a separate system for broadcasters; an essentially self-regulated system under IPSO for newspapers; and then there is the issue of how we make sure that what happens online is properly regulated as well. I will come on to that...
We have three separate systems of media regulation in this country: a separate system for broadcasters; an essentially self-regulated system under IPSO for newspapers; and then there is the issue of how we make sure that what happens online is properly regulated as well. I will come on to that...
It did, yes. I am trying to ensure that we have a debate on these measures that takes into account the fact that, yes, we want a free press that can hold the powerful to account, but also that it is fair. I know—as does everyone in this House—that there...
It did, yes. I am trying to ensure that we have a debate on these measures that takes into account the fact that, yes, we want a free press that can hold the powerful to account, but also that it is fair. I know—as does everyone in this House—that there...
My hon. Friend is completely right about the gap between online and print in terms of standards of regulation. That is because IPSO was brought into force—I was glad to see it being introduced in 2014. He is also right that tackling the problems online is critical. Our internet safety...
My hon. Friend is completely right about the gap between online and print in terms of standards of regulation. That is because IPSO was brought into force—I was glad to see it being introduced in 2014. He is also right that tackling the problems online is critical. Our internet safety...
I have a lot of sympathy with the views of my hon. Friend. The MailOnline is, of course, an online publication, and we are looking at that as part of our internet safety strategy. I am very happy to talk to him about how that can be done. Only in...
I have a lot of sympathy with the views of my hon. Friend. The MailOnline is, of course, an online publication, and we are looking at that as part of our internet safety strategy. I am very happy to talk to him about how that can be done. Only in...
That is absolutely right. The minimum access cost will be £50, which means that everybody has access to justice at low cost. There is more to it than that, however. Some people argue that the £60,000 limit on damages is too low, but the arbitration scheme does not stop somebody...
That is absolutely right. The minimum access cost will be £50, which means that everybody has access to justice at low cost. There is more to it than that, however. Some people argue that the £60,000 limit on damages is too low, but the arbitration scheme does not stop somebody...
I agree with the sentiment, which is that we have to ensure that the press remains free but also fair and reasonable, and that is the purpose of the amendment proposing a review period of four years. We will not let matters lie.
Some have asked, “What happens if newspapers pull...
I agree with the sentiment, which is that we have to ensure that the press remains free but also fair and reasonable, and that is the purpose of the amendment proposing a review period of four years. We will not let matters lie.
Some have asked, “What happens if newspapers pull...
Given that this is a Data Protection Bill, the review will consider data protection issues, but I would expect it to be as broad as necessary, to ensure that all those matters are considered.
We have listened to concerns raised during the passage of the Bill, including in this debate.
Given that this is a Data Protection Bill, the review will consider data protection issues, but I would expect it to be as broad as necessary, to ensure that all those matters are considered.
We have listened to concerns raised during the passage of the Bill, including in this debate.
On the contrary, the scheme introduces new, compulsory, low-cost arbitration to ensure that people can have exactly the recourse to justice mentioned by the right hon. Gentleman. In order to address some of the concerns, we have tabled two new clauses. First, new clause 19 requires the Information Commissioner to...
On the contrary, the scheme introduces new, compulsory, low-cost arbitration to ensure that people can have exactly the recourse to justice mentioned by the right hon. Gentleman. In order to address some of the concerns, we have tabled two new clauses. First, new clause 19 requires the Information Commissioner to...